Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $192.84 million. The enterprise value is $132.21 million.
| Market Cap | 192.84M |
| Enterprise Value | 132.21M |
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 63.23 million shares outstanding. The number of shares has increased by 104.50% in one year.
| Current Share Class | 63.23M |
| Shares Outstanding | 63.23M |
| Shares Change (YoY) | +104.50% |
| Shares Change (QoQ) | +4.79% |
| Owned by Insiders (%) | 10.49% |
| Owned by Institutions (%) | 38.18% |
| Float | 33.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.24 |
| P/TBV Ratio | 3.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.62, with a Debt / Equity ratio of 0.01.
| Current Ratio | 18.62 |
| Quick Ratio | 18.33 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.39% and return on invested capital (ROIC) is -35.84%.
| Return on Equity (ROE) | -54.39% |
| Return on Assets (ROA) | -31.91% |
| Return on Invested Capital (ROIC) | -35.84% |
| Return on Capital Employed (ROCE) | -34.11% |
| Weighted Average Cost of Capital (WACC) | 13.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.27M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +824.24% in the last 52 weeks. The beta is 1.78, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +824.24% |
| 50-Day Moving Average | 2.36 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 62.09 |
| Average Volume (20 Days) | 1,170,296 |
Short Selling Information
The latest short interest is 3.61 million, so 5.70% of the outstanding shares have been sold short.
| Short Interest | 3.61M |
| Short Previous Month | 2.87M |
| Short % of Shares Out | 5.70% |
| Short % of Float | 10.75% |
| Short Ratio (days to cover) | 9.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.37M |
| Pretax Income | -19.06M |
| Net Income | -19.06M |
| EBITDA | -20.27M |
| EBIT | -20.37M |
| Earnings Per Share (EPS) | -$0.27 |
Balance Sheet
The company has $61.32 million in cash and $692,000 in debt, with a net cash position of $60.63 million or $0.96 per share.
| Cash & Cash Equivalents | 61.32M |
| Total Debt | 692,000 |
| Net Cash | 60.63M |
| Net Cash Per Share | $0.96 |
| Equity (Book Value) | 59.49M |
| Book Value Per Share | 0.94 |
| Working Capital | 58.93M |
Cash Flow
In the last 12 months, operating cash flow was -$18.88 million and capital expenditures -$47,000, giving a free cash flow of -$18.93 million.
| Operating Cash Flow | -18.88M |
| Capital Expenditures | -47,000 |
| Depreciation & Amortization | 107,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -18.93M |
| FCF Per Share | -$0.30 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -104.50% |
| Shareholder Yield | -104.50% |
| Earnings Yield | -9.88% |
| FCF Yield | -9.81% |
Analyst Forecast
The average price target for Equillium is $7.13, which is 133.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.13 |
| Price Target Difference | 133.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |